Myopia Profile

Clinical

Beyond the basics: sustaining ortho-k success over the long term

Posted on June 25th 2026 by Jeanne Saw

Sponsored by

menicon_logo_color.png

In this article:

This article takes a look at the challenges that arise during the longer-term phase of ortho-k care and strategies to combat them.


Getting a child started on orthokeratology is a meaningful step. But the real work — and the real opportunity — lies in what comes after. For many practitioners, maintaining momentum beyond the initial prescription is where the clinical relationship becomes most impactful, and where gaps in engagement can lead to treatment drop-out and missed outcomes. This article takes a practical look at the challenges that arise during the longer-term phase of ortho-k care: managing expectations, sustaining adherence, recognising warning signs of disengagement, and supporting families through the full arc of myopia management.

Why long-term engagement matters

Myopia management is not a single intervention: it is a long-term commitment, often spanning the most critical years of ocular development. The benefit of slowing axial elongation accumulates over time, which means that each year of consistent treatment contributes meaningfully to reducing a child’s lifetime risk of myopia-related complications, including retinal detachment, glaucoma and myopic maculopathy. 

Despite this, dropout is a recognised challenge across all myopia management modalities. Among optical modalities, spectacle-based treatments show the lowest discontinuation rates, reflecting their simplicity and minimal ocular demands. Soft contact lenses show the highest dropout rates, likely due to the behavioural and physiological demands of daily wear. Orthokeratology sits between the two, with retention influenced by adaptation requirements and the potential for mild ocular events associated with overnight wear.1 

In clinical practice, the picture may be more encouraging: a retrospective study from a single hospital found an orthokeratology dropout rate as low as 2%, in contrast to the 7% to 54% range observed across prospective orthokeratology trials.2  This discrepancy is likely to reflect the difference between real-world patients who have actively chosen treatment and trial participants operating under protocol constraints. Nevertheless, the variability is a useful reminder that outcomes depend significantly on how well patients are selected, prepared, and supported over time.

Understanding why patients disengage

Disengagement from ortho-k in real-world clinical settings is often driven by a combination of practical, personal, and physiological factors. While studies show that ortho-k has a moderate dropout rate compared to other modalities,1  understanding these specific barriers can help you better support your patients and their families. The reasons patients discontinue ortho-k include:

Early experiences and Adherence Challenges

  • Early phase frustration: The first few weeks of ortho-k wear carry the highest risk of early discontinuation. Mild discomfort, awareness of the lens during insertion or removal, and variable visual clarity during the adaptation period can all undermine confidence.
  • Lens care challenges: While patients generally avoid using expired lens cleaning solutions, studies show poor adherence to intensive care practices (e.g., removing lens protein buildup) and case replacement intervals.3  A common challenge is exposing lenses to nonsterile environments, including tap water, which increases the risk of serious complications like Acanthamoeba or microbial keratitis.4,5  The daily responsibilities of cleaning, storing, and caring for ortho-k lenses and accessories can become burdensome over time and therefore cause patients to dropout. 
  • Changing lifestyle: Patients (especially older children and adolescents) may develop habits of wearing lenses for shorter sleep times or skipping nights entirely, which leads to fluctuating daytime vision and can degrade myopia control efficacy.

Patient & Parent Expectations

  • Expecting immediate results: Some patients and parents begin ortho-k expecting a quick outcome, but achieving stable vision and successful myopia control can take time. When early results do not match potentially unrealistic expectations, motivation can decline.
  • Managing reversibility: Ortho-k requires ongoing wear to maintain its effects. Missing nights or stopping treatment can lead to visual fluctuations and regression, which may frustrate patients and families who were expecting a more permanent outcome.

Follow-Up Fatigue

  • Perceived lack of need: Once patients achieve clear daytime vision, they may feel that treatment is working well and no longer see the value of routine follow-up visits.6 
  • Practical inconvenience: Follow-up visits can begin to feel disruptive to school, work, and family schedules.
  • Competing priorities: As children progress through school, extracurricular activities, exams, and social commitments can take precedence over routine eye care appointments.

Follow-up compliance drops drastically after the initial few months, with studies showing attendance can decline from 97% in primary school users down to 77% in senior high school wearers.7  Reduced attendance can limit opportunities to monitor eye health, assess treatment effectiveness, and reinforce good lens care habits. Regular appointments also allow us to identify early signs of declining motivation or treatment fatigue, allowing concerns to be addressed before they lead to treatment discontinuation. 

Maintaining momentum in practice

While some degree of treatment discontinuation is inevitable, many of the factors that contribute to disengagement can be addressed through proactive patient management. Setting realistic expectations from the outset is particularly important. Families should understand that ortho-k is a long-term treatment requiring consistent overnight wear and regular follow-up visits to achieve and maintain optimal outcomes. Preparing patients for the adaptation period, including possible lens awareness and temporary fluctuations in vision, can also help reduce early frustration and manage expectations. Regular reassurance at the very beginning is key. 

Follow-up visits provide valuable opportunities to reinforce good lens care habits, address concerns, and remind families of the long-term goal of stable, clear daytime vision and slowing myopia progression. Proactive recall systems (rather than relying on families to self-initiate appointments) are one of the most straightforward ways to maintain continuity of care. Knowing when a family is due for a check-up and reaching out before the appointment window lapses sends a signal that ongoing engagement is expected and valued, rather than optional. 

Simple measures such as providing clear lens care instructions, using appointment reminders, and celebrating treatment milestones can help reduce the burden of treatment and strengthen long-term adherence. Systems such as the Menicon BloomTM ecosystem and mobile phone app (see image 1) integrate all this into a digital interface that supports sustained engagement by facilitating communication and tracking between visits. 

MBAPP_MBN.png

Image 1: The Menicon Bloom™ patient app facilitates ongoing tracking of contact lens wear by collecting outcomes reported by patients related to comfort, handling, and vision. These data can assist practitioners in identifying challenges early and supporting successful treatment adherence.

Final thoughts

The initial prescription of ortho-k marks the start of a long-term treatment journey. The full value of treatment for the child, family, and practitioner is realised through sustained engagement that extends well beyond the first fitting. Supporting families over time requires an understanding of the practical challenges they may encounter, communication strategies that evolve as children become more independent, and clinical systems that facilitate ongoing, meaningful care.

Practitioners who invest in long-term patient relationships through structured follow-up, proactive communication, and the effective use of clinical data are better positioned to support continued engagement with treatment. In doing so, they can help maximise both treatment adherence and myopia control outcomes during the years when effective management matters most.


Meet the Authors:

About Jeanne Saw

Jeanne is a clinical optometrist based in Sydney, Australia. She has worked as a research assistant with leading vision scientists, and has a keen interest in myopia control and professional education.

As Manager, Professional Affairs and Partnerships, Jeanne works closely with Dr Kate Gifford in developing content and strategy across Myopia Profile's platforms, and in working with industry partners. Jeanne also writes for the CLINICAL domain of MyopiaProfile.com, and the My Kids Vision website, our public awareness platform. 


This content is brought to you thanks to an educational grant from

Gold Sponsor

Back to all articles

Enormous thanks to our visionary sponsors

Myopia Profile’s growth into a world leading platform has been made possible through the support of our visionary sponsors, who share our mission to improve children’s vision care worldwide. Click on their logos to learn about how these companies are innovating and developing resources with us to support you in managing your patients with myopia.